Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALUR Allurion Technologies	$0.68 +0.0%	$0.74	$0.23 ▼ $3.42	$10.20M	-0.18	1.88 million shs	18,409 shs
LFWD Lifeward	$6.45 -4.6%	$6.76	$4.14 ▼ $17.76	$9.86M	0.32	20,377 shs	11,804 shs
MBAI Check-Cap	$1.45 -2.7%	$1.67	$0.59 ▼ $3.92	$10.57M	0.57	1.79 million shs	11,646 shs
NUWE Nuwellis	$1.09 -0.9%	$1.20	$0.96 ▼ $43.26	$2.68M	0.25	1.51 million shs	16,899 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALUR Allurion Technologies	-1.47%	-0.64%	-16.25%	-39.64%	-71.49%
LFWD Lifeward	-3.43%	-7.14%	+2.74%	-1.17%	-58.27%
MBAI Check-Cap	+4.20%	+1.36%	-8.59%	-10.24%	+148,999,900.00%
NUWE Nuwellis	+0.92%	-2.65%	-2.65%	-57.85%	-97.21%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALUR Allurion Technologies	$0.68 +0.0%	$0.74	$0.23 ▼ $3.42	$10.20M	-0.18	1.88 million shs	18,409 shs
LFWD Lifeward	$6.45 -4.6%	$6.76	$4.14 ▼ $17.76	$9.86M	0.32	20,377 shs	11,804 shs
MBAI Check-Cap	$1.45 -2.7%	$1.67	$0.59 ▼ $3.92	$10.57M	0.57	1.79 million shs	11,646 shs
NUWE Nuwellis	$1.09 -0.9%	$1.20	$0.96 ▼ $43.26	$2.68M	0.25	1.51 million shs	16,899 shs

Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALUR Allurion Technologies	-1.47%	-0.64%	-16.25%	-39.64%	-71.49%
LFWD Lifeward	-3.43%	-7.14%	+2.74%	-1.17%	-58.27%
MBAI Check-Cap	+4.20%	+1.36%	-8.59%	-10.24%	+148,999,900.00%
NUWE Nuwellis	+0.92%	-2.65%	-2.65%	-57.85%	-97.21%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALUR Allurion Technologies	2.00	Hold	$3.00	341.18% Upside
LFWD Lifeward	2.00	Hold	$10.00	55.04% Upside
MBAI Check-Cap	1.00	Sell	N/A	N/A
NUWE Nuwellis	2.00	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, LFWD, and ALUR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/24/2026	MBAI Check-Cap	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
4/21/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
3/27/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
3/19/2026	LFWD Lifeward	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$10.00
2/24/2026	ALUR Allurion Technologies	Chardan Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Neutral ➝ Buy	$2.50 ➝ $3.00
2/24/2026	ALUR Allurion Technologies	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$3.00

(Data available from 5/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALUR Allurion Technologies	$17.21M	0.59	N/A	N/A	($30.08) per share	-0.02
LFWD Lifeward	$22.03M	0.45	N/A	N/A	$5.52 per share	1.17
MBAI Check-Cap	N/A	N/A	$0.58 per share	2.52	$0.47 per share	N/A
NUWE Nuwellis	$8.27M	0.32	N/A	N/A	$1.58 per share	0.69

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALUR Allurion Technologies	-$7.20M	-$10.56	N/A	N/A	N/A	-199.96%	N/A	-77.13%	5/13/2026 (Estimated)
LFWD Lifeward	-$19.91M	-$18.49	N/A	N/A	N/A	-90.38%	-145.55%	-78.36%	5/21/2026 (Estimated)
MBAI Check-Cap	$4.14M	-$2.77	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	-$17.52M	-$90.92	N/A	N/A	N/A	-211.86%	-6,094.26%	-231.24%	5/12/2026 (Estimated)

Latest NUWE, MBAI, LFWD, and ALUR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/21/2026	Q1 2026	LFWD Lifeward	-$1.18	N/A	N/A	N/A	$5.78 million	N/A
5/13/2026	Q1 2026	ALUR Allurion Technologies	-$0.34	N/A	N/A	N/A	$3.10 million	N/A
5/12/2026	Q1 2026	NUWE Nuwellis	-$1.00	N/A	N/A	N/A	$2.09 million	N/A
3/19/2026	Q4 2025	LFWD Lifeward	-$0.07	-$3.60	-$3.53	-$3.60	$7.87 million	$5.08 million
3/10/2026	Q4 2025	NUWE Nuwellis	-$1.56	-$1.50	+$0.06	-$1.50	$2.31 million	$2.42 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALUR Allurion Technologies	N/A	N/A	N/A	N/A	N/A
LFWD Lifeward	N/A	N/A	N/A	N/A	N/A
MBAI Check-Cap	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALUR Allurion Technologies	N/A	1.26	0.94
LFWD Lifeward	N/A	1.31	0.84
MBAI Check-Cap	N/A	0.05	0.05
NUWE Nuwellis	N/A	1.71	1.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALUR Allurion Technologies	21.39%
LFWD Lifeward	26.76%
MBAI Check-Cap	1.07%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
ALUR Allurion Technologies	8.10%
LFWD Lifeward	1.50%
MBAI Check-Cap	0.48%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALUR Allurion Technologies	501	14.99 million	11.28 million	No Data
LFWD Lifeward	60	1.53 million	1.51 million	Optionable
MBAI Check-Cap	80	7.29 million	7.25 million	N/A
NUWE Nuwellis	70	2.46 million	2.42 million	Not Optionable

NUWE, MBAI, LFWD, and ALUR Headlines

Recent News About These Companies

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

May 5 at 8:00 AM | globenewswire.com

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

April 29, 2026 | globenewswire.com

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

April 28, 2026 | globenewswire.com

Nuwellis Settles Lawsuit With E.F. Hutton, Resolving Dispute

April 26, 2026 | theglobeandmail.com

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

April 23, 2026 | globenewswire.com

Nuwellis Announces Aquadex Software Update

April 21, 2026 | globenewswire.com

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

April 16, 2026 | globenewswire.com

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

April 9, 2026 | globenewswire.com

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

April 7, 2026 | globenewswire.com

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

March 31, 2026 | globenewswire.com

Nuwellis Board Directors Resign Amid Governance Dispute

March 29, 2026 | theglobeandmail.com

Nuwellis Completes Acquisition of Rendiatech

March 17, 2026 | globenewswire.com

Nuwellis, Inc. (NASDAQ: NUWE) Q4 2025 earnings call transcript

March 11, 2026 | msn.com

Nuwellis, Inc. (NASDAQ:NUWE) Q4 2025 Earnings Call Transcript

March 11, 2026 | insidermonkey.com

Nuwellis, Inc. Q4 2025 Earnings Call Summary

March 10, 2026 | finance.yahoo.com

Nuwellis, Inc. (NUWE) Q4 2025 Earnings Call Transcript

March 10, 2026 | seekingalpha.com

Nuwellis (NUWE) Q4 2025 Earnings Call Transcript

March 10, 2026 | fool.com

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

March 10, 2026 | globenewswire.com

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

March 5, 2026 | globenewswire.com

Nuwellis Sets Date for Annual Financial Disclosure

March 4, 2026 | aktiencheck.deA

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, LFWD, and ALUR Company Descriptions

Allurion Technologies NYSE:ALUR

$0.68 +0.00 (+0.01%)

As of 11:50 AM Eastern

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Lifeward NASDAQ:LFWD

$6.45 -0.31 (-4.59%)

As of 12:04 PM Eastern

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Check-Cap NASDAQ:MBAI

$1.45 -0.04 (-2.68%)

As of 12:08 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Nuwellis NASDAQ:NUWE

$1.09 -0.01 (-0.91%)

As of 12:00 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, LFWD, and ALUR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, MBAI, LFWD, and ALUR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, MBAI, LFWD, and ALUR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, LFWD, and ALUR Company Descriptions

Allurion Technologies NYSE:ALUR

Lifeward NASDAQ:LFWD

Check-Cap NASDAQ:MBAI

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, MBAI, LFWD, and ALUR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, MBAI, LFWD, and ALUR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, MBAI, LFWD, and ALUR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, MBAI, LFWD, and ALUR Company Descriptions

Allurion Technologies NYSE:ALUR

Lifeward NASDAQ:LFWD

Check-Cap NASDAQ:MBAI

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools